Trial
NCT07172022
A Study to Evaluate Crovalimab in People With Antiphospholipid Syndrome (APS)
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Hoffmann-La Roche
Collaborators
—
Condition
Antiphospholipid Syndrome
Intervention
Crovalimab
Why stopped
The study was discontinued due to a strategic business/portfolio decision by the sponsor and was not related to any medical or safety issue.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-03-02